Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An approach to the validation of novel molecular markers of breast cancer via TMA-based FISH scanning.

Journal of molecular histology - 1 May 2007

Tubbs Raymond R, Swain Eric, Pettay James D, Hicks David G

Abstract excerpt

Tissue microarrays (TMA) are valuable tools for validating results of array-based comparative genomic hybridization (ACGH) and other translational research applications requiring independent verification of genomic gains and losses by fluorescence in situ hybridization (FISH). However, spatial or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Centromere

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 17

Share to In Situ Hybridization, Fluorescence

Share to Nucleic Acid Hybridization

Share to Receptor, ErbB-2

Share to Tissue Array Analysis

Source

Identifiers

PMID: 17211577
DOI: 10.1007/s10735-006-9076-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17211577-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

An approach to the validation of novel molecular markers of breast cancer via TMA-based FISH scanning.PMID 17211577Read ↗

Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as modelsSemantic proximity Read ↗

Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast CancerSemantic proximity Read ↗

Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancersSemantic proximity Read ↗

Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicineSemantic proximity Read ↗

The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.Semantic proximity Read ↗

Molecular Markers Guiding Thyroid Cancer ManagementSemantic proximity Read ↗

Fluorescence in situ hybridization in surgical pathology: principles and applicationsSemantic proximity Read ↗

Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.